4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0000950170-24-086146
Options or other derivatives
- President, CEO and CFO acquired 440,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Quinn William P. President, CEO and CFO | 2024-07-23 | Grant or award · Stock Option (Right to Buy) | +440,000 | 440,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…